Cited by 348Nanoparticle-Based Drug DeliveryDrug Transport and Resistance MechanismsNanoplatforms for cancer theranostics

The DOI matches its Crossref record; 240 of the 242 references it cites were found in a registry or an index.

Role of integrated cancer nanomedicine in overcoming drug resistance

Iyer, Arun K., Singh, Amit, Ganta, Srinivas, Amiji, Mansoor M.·2013·Advanced Drug Delivery Reviews

DOI 10.1016/j.addr.2013.07.012

Open this paper in CoChat — free account

Abstract

Cancer remains a major killer of mankind. Failure of conventional chemotherapy has resulted in recurrence and development of virulent multi drug resistant (MDR) phenotypes adding to the complexity and diversity of this deadly disease. Apart from displaying classical physiological abnormalities and aberrant blood flow behavior, MDR cancers exhibit several distinctive features such as higher apoptotic threshold, aerobic glycolysis, regions of hypoxia, and elevated activity of drug-efflux transporters. MDR transporters play a pivotal role in protecting the cancer stem cells (CSCs) from chemotherapy. It is speculated that CSCs are instrumental in reviving tumors after the chemo and radiotherapy. In this regard, multifunctional nanoparticles that can integrate various key components such as drugs, genes, imaging agents and targeting ligands using unique delivery platforms would be more efficient in treating MDR cancers. This review presents some of the important principles involved in development of MDR and novel methods of treating cancers using multifunctional-targeted nanoparticles. Illustrative examples of nanoparticles engineered for drug/gene combination delivery and stimuli responsive nanoparticle systems for cancer therapy are also discussed.

Integrity signals

Registry

Crossref · 10.1016/j.addr.2013.07.012

Cites

240 of 240 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Prospective identification of tumorigenic breast cancer cells
Al‐Hajj, M., Wicha, M. S., Benito‐Hernández, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,579
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
Bonnet, D. A., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 7,197
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature reviews. Cancer · doi:10.1038/nrc822 · Cited by 6,767
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple
Schafer, F. Q., & Buettner, G. R. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00480-4 · Cited by 4,587

Flagged first, then by citations

Show all 242 references

2 of the 242 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

Hortobagyi, 1997, Anthracyclines in the treatment of cancer. An overview, Drugs, 54, 1
Jabr-Milane, 2008, Multi-functional nanocarriers to overcome tumor drug resistance, Cancer Treat. Rev., 34, 592, 10.1016/j.ctrv.2008.04.003 · DOI
Lavignac, 2004, Synthesis and endosomolytic properties of poly(amidoamine) block copolymers, Macromol. Biosci., 4, 922, 10.1002/mabi.200400093 · DOI

Sorted by citations

Items 101–200 of 348

Cancer resistance to treatment and antiresistance tools offered by multimodal multifunctional nanoparticles
Casals, E., Gustà, M. F., Cobaleda‐Siles, M., García, A., & Puntes, V. (2017) · Cancer Nanotechnology · doi:10.1186/s12645-017-0030-4 · Cited by 56
Raloxifene-encapsulated hyaluronic acid-decorated chitosan nanoparticles selectively induce apoptosis in lung cancer cells
Almutairi, F. M., Abdrabou, A., & Mohamed, M. S. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.03.004 · Cited by 55
111In- and IRDye800CW-Labeled PLA–PEG Nanoparticle for Imaging Prostate-Specific Membrane Antigen-Expressing Tissues
Banerjee, S. R., Foss, C. A., Horhota, A., Pullambhatla, M., McDonnell, K., Zale, S., & Pomper, M. G. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.6b01485 · Cited by 54
B3O3 monolayer with dual application in sensing of COVID-19 biomarkers and drug delivery for treatment purposes: A periodic DFT study
Rahimi, R., & Solimannejad, M. (2022) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2022.118855 · Cited by 53
Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells
Zubrilov, I., Sagi‐Assif, O., Izraely, S., Meshel, T., Ben‐Menachem, S., Ginat, R., Pasmanik, M., Nahmias, C., Couraud, P., Hoon, D. S. �., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.02.041 · Cited by 53
Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac
Sudha, T., Bharali, D. J., Yalçın, M., Darwish, N. H. E., Coskun, M. D., Keating, K. A., Lin, H., Davis, P. J., & Mousa, S. A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s123742 · Cited by 51
Harnessing cancer stem cell-derived exosomes to improve cancer therapy
Yang, J., & Teng, Y. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02717-x · Cited by 50
Co-delivery strategies to overcome multidrug resistance in ovarian cancer
Khan, I. U., Khan, I. U., Asif, H., Alamgeer, Khalid, S. H., Asghar, S., Saleem, M., Shah, K. U., Shah, S. U., Rizvi, S. A. A., et al. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.09.060 · Cited by 51
Co-delivery of Poria cocos extract and doxorubicin as an ‘all-in-one’ nanocarrier to combat breast cancer multidrug resistance during chemotherapy
Li, Y., Li, X., Lu, Y., Chaurasiya, B., Mi, G., Shi, D., Chen, D., Webster, T. J., Tu, J., & Shen, Y. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.102095 · Cited by 49
CXCL-13 Regulates Resistance to 5-Fluorouracil in Colorectal Cancer
Zhang, G., Luo, X., Zhang, W., Chen, E., Xu, J., Wang, F., Cao, G., Ju, Z., Jin, D., Huang, X., et al. (2019) · Cancer Research and Treatment · doi:10.4143/crt.2019.593 · Cited by 48
Poly(amino ester)s as an emerging synthetic biodegradable polymer platform: Recent developments and future trends
Wang, X., Zhang, Z., & Hadjichristidis, N. (2022) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2022.101634 · Cited by 49
Nanodelivery systems: An efficient and target‐specific approach for drug‐resistant cancers
Ashique, S., Garg, A., Hussain, A., Farid, A., Kumar, P., & Taghizadeh‐Hesary, F. (2023) · Cancer Medicine · doi:10.1002/cam4.6502 · Cited by 51
Photostable and Biocompatible Fluorescent Silicon Nanoparticles for Imaging-Guided Co-Delivery of siRNA and Doxorubicin to Drug-Resistant Cancer Cells
Guo, D., Ji, X., Fei, P., Zhong, Y., Chu, B., Su, Y., & He, Y. (2019) · Nano-Micro Letters · doi:10.1007/s40820-019-0257-1 · Cited by 48
Insulin-like growth factor 2 mRNA-binding protein 2-stabilized long non-coding RNA Taurine up-regulated gene 1 (TUG1) promotes cisplatin-resistance of colorectal cancer via modulating autophagy
Xia, C., Li, Q., Cheng, X., Wu, T., Gao, P., & Gu, Y. (2022) · Bioengineered · doi:10.1080/21655979.2021.2012918 · Cited by 47
A study on DPL model of heat transfer in bi-layer tissues during MFH treatment
Kumar, D., Kumar, P., & Rai, K. N. (2016) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2016.06.002 · Cited by 44
A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells
Orienti, I., Salvati, V., Sette, G., Zucchetti, M., Bongiorno‐Borbone, L., Peschiaroli, A., Zolla, L., Francescangeli, F., Ferrari, M., Matteo, C., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1383-9 · Cited by 44
Synergistic effect between poly(diallyldimethylammonium chloride) and reduced graphene oxide for high electrochemically active biofilm in microbial fuel cell
Chen, X., Li, Y., Yuan, X., Li, N., He, W., & Liu, J. (2020) · Electrochimica Acta · doi:10.1016/j.electacta.2020.136949 · Cited by 44
Voltage/pH-Driven Mechanized Silica Nanoparticles for the Multimodal Controlled Release of Drugs
Wang, T., Sun, G., Wang, M., Zhou, B., & Fu, J. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b05619 · Cited by 43
Advanced cancer therapy by integrative antitumor actions via systemic administration of miR-499
Ando, H., Asai, T., Koide, H., Okamoto, A., Maeda, N., Tomita, K., Dewa, T., Minamino, T., & Oku, N. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.02.019 · Cited by 43
Enhanced Antiproliferative Effect of Carboplatin in Cervical Cancer Cells Utilizing Folate-Grafted Polymeric Nanoparticles
Ji, J., Zuo, P., & Wang, Y. (2015) · Nanoscale Research Letters · doi:10.1186/s11671-015-1162-2 · Cited by 43
Lanthanide-integrated supramolecular polymeric nanoassembly with multiple regulation characteristics for multidrug-resistant cancer therapy
Jin, W., Wang, Q., Wu, M., Li, Y., Tang, G., Yuan, P., & Chu, P. K.-H. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.03.020 · Cited by 43
Magnetotactic Bacteria-Based Drug-Loaded Micromotors for Highly Efficient Magnetic and Biological Double-Targeted Tumor Therapy
Wang, B., Qin, Y., Liu, J., Zhang, Z., Li, W., Pu, G., Yuanhe, Z., Gui, X., & Chu, M. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c19960 · Cited by 41
Role ofpH-responsiveness in the design of chitosan-based cancer nanotherapeutics: A review
Suarato, G., Li, W., & Meng, Y. (2016) · Biointerphases · doi:10.1116/1.4944661 · Cited by 42
Paclitaxel-Potentiated Photodynamic Theranostics for Synergistic Tumor Ablation and Precise Anticancer Efficacy Monitoring
Wang, X., Tong, J., He, Z., Yang, X., Meng, F., Liang, H., Zhang, X., & Luo, L. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b19073 · Cited by 42
NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?
Friberg, S. G., & Nyström, A. M. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0172-2 · Cited by 43
Novel transferrin modified and doxorubicin loaded Pluronic 85/lipid-polymeric nanoparticles for the treatment of leukemia: In vitro and in vivo therapeutic effect evaluation
Zhu, B., Zhang, H., & Yu, L. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.121 · Cited by 41
Delivery of miR-320a-3p by gold nanoparticles combined with photothermal therapy for directly targeting Sp1 in lung cancer
Peng, J., Wang, R., Sun, W., Huang, M., Wang, R., Li, Y., Wang, P., Sun, G., & Xie, S. (2021) · Biomaterials Science · doi:10.1039/d1bm01124c · Cited by 42
Smart strategies to overcome tumor hypoxia toward the enhancement of cancer therapy
Xu, M., Wang, P., Sun, S., Gao, L., Sun, L., Zhang, L., Zhang, J., Wang, S., & Liang, X. (2020) · Nanoscale · doi:10.1039/d0nr05501h · Cited by 40
Targeting P-glycoprotein expression and cancer cell energy metabolism: combination of metformin and 2-deoxyglucose reverses the multidrug resistance of K562/Dox cells to doxorubicin
Xue, C., Wang, C., Liu, Q., Meng, Q., Sun, H., Huo, X., Ma, X., Liu, Z., Ma, X., Peng, J., et al. (2016) · Tumor Biology · doi:10.1007/s13277-015-4478-8 · Cited by 39
Copper-Free ‘Click’ Chemistry-Based Synthesis and Characterization of Carbonic Anhydrase-IX Anchored Albumin-Paclitaxel Nanoparticles for Targeting Tumor Hypoxia
Tatiparti, K., Sau, S., Gawde, K. A., & Iyer, A. K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030838 · Cited by 38
Self-citation
RETRACTED: Lnc RNA FENDRR attenuates adriamycin resistance via suppressing MDR 1 expression through sponging HuR and miR‐184 in chronic myelogenous leukaemia cells
Zhang, F., Ni, H., Li, X., Liu, H., Xi, T., & Zheng, L. (2019) · FEBS Letters · doi:10.1002/1873-3468.13480 · Cited by 38
Retracted
Impact of Molybdenum Compounds as Anticancer Agents
Odularu, A. T., Ajibade, P. A., & Mbese, J. Z. (2019) · Bioinorganic Chemistry and Applications · doi:10.1155/2019/6416198 · Cited by 38
Synergistic chemotherapy and phototherapy based on red blood cell biomimetic nanomaterials
Meng, D., Yang, S., Yang, Y., Zhang, L., & Cui, L. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.10.019 · Cited by 41
Efficiency against multidrug resistance by co-delivery of doxorubicin and curcumin with a legumain-sensitive nanocarrier
Lin, S., Xie, P., Luo, M., Li, Q., Li, L., Zhang, J., Zheng, Q., Chen, H., & Nan, K. (2017) · Nano Research · doi:10.1007/s12274-017-1928-1 · Cited by 36
Ingenious pH-sensitive etoposide loaded folic acid decorated mesoporous silica-carbon dot with carboxymethyl-βcyclodextrin gatekeeper for targeted drug delivery and imaging
Shirani, M. P., Rezaei, B., Khayamian, T., Dinari, M., Shamili, F. H., Ramezani, M., & Alibolandi, M. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.07.043 · Cited by 37
When metal–organic framework mediated smart drug delivery meets gastrointestinal cancers
Hashemzadeh, A., Drummen, G. P. C., Avan, A., Darroudi, M., Khazaei, M., Khajavian, R., Rangrazi, A., & Mirzaei, M. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb00155h · Cited by 37
Zwitterion-functionalized hollow mesoporous Prussian blue nanoparticles for targeted and synergetic chemo-photothermal treatment of acute myeloid leukemia
Bai, H., Sun, Q., Kong, F., Dong, H., Ma, M., Liu, F., Wang, C., Xu, H., Gu, N., & Zhang, Y. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb00548k · Cited by 36
Comparison of cytotoxicity between extracts of Clinacanthus nutans (Burm. f.) Lindau leaves from different locations and the induction of apoptosis by the crude methanol leaf extract in D24 human melanoma cells
Fong, S. Y., Piva, T. J., Dekiwadia, C. D., Urban, S., & Huynh, T. T. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1348-x · Cited by 36
Expression of P2X7R in breast cancer tissue and the induction of apoptosis by the gene-specific shRNA in MCF-7 cells
Tan, C., HAN, L., Zou, L., Chunhua, L., Liu, A., Sheng, X., & Xi, D. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2705 · Cited by 35
Retracted
Regulatory Aspects of Oncologicals: Nanosystems Main Challenges
Gaspar, R. S., Florindo, H. F., Silva, L. C., Videira, M., Corvo, M. L., Martins, M. B. F., & Lima, B. S. (2014) · Advances in delivery science and technology · doi:10.1007/978-3-319-08084-0_15 · Cited by 35
Silencing the roadblocks to effective triple-negative breast cancer treatments by siRNA nanoparticles
Parvani, J. G., & Jackson, M. W. (2017) · Endocrine Related Cancer · doi:10.1530/erc-16-0482 · Cited by 35
A Simple, Yet Multifunctional, Nanoformulation for Eradicating Tumors and Preventing Recurrence with Safely Low Administration Dose
Liu, Y., Xu, Y., Zhang, Z., Huo, Y., Chen, D., Ma, W., Sun, K., Tonga, G. Y., Zhou, G., Kohane, D. S., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b02053 · Cited by 33
The Synergistic Anticancer Effect of Dual Drug- (Cisplatin/Epigallocatechin Gallate) Loaded Gelatin Nanoparticles for Lung Cancer Treatment
Chen, Y., Wang, Z.-W., Lu, T.-L., Gomez, C. B., Fang, H.-W., Wei, Y., & Tseng, C. (2020) · Journal of Nanomaterials · doi:10.1155/2020/9181549 · Cited by 34
Molecular Docking, Drug Likeness, and ADMET Analyses of Passiflora Compounds as P-Glycoprotein (P-gp) Inhibitor for the Treatment of Cancer
Yalçın, S. (2020) · Current Pharmacology Reports · doi:10.1007/s40495-020-00241-6 · Cited by 34
Novel Platinum Nanoclusters Activate PI3K/AKT/mTOR Signaling Pathway-Mediated Autophagy for Cisplatin-Resistant Ovarian Cancer Therapy
Zhang, M., Yue, H., Huang, X., Wang, J., Li, Z., & Deng, X. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c15143 · Cited by 34
Nano-immunotherapy for lung cancer
Lu, Y., Zeng, T., Zhang, H., Li, Y., Zhu, X., Liu, H., Sun, B., Ji, C., Li, T., Huang, L., et al. (2023) · Nano TransMed · doi:10.26599/ntm.2023.9130018 · Cited by 33
Enhanced anti-tumor efficacy and safety with metronomic intraperitoneal chemotherapy for metastatic ovarian cancer using biodegradable nanotextile implants
Padmakumar, S., Parayath, N. N., Nair, S. V., Menon, D., & Amiji, M. M. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.05.022 · Cited by 33
Self-citation
Ultrasmall nanostructured drug based pH-sensitive liposome for effective treatment of drug-resistant tumor
Li, Y., Zhai, Y., Liu, W., Zhang, K., Liu, J., Shi, J., & Zhang, Z. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0550-7 · Cited by 33
Recent Advances in Asialoglycoprotein Receptor and Glycyrrhetinic Acid Receptor-Mediated and/or pH-Responsive Hepatocellular Carcinoma- Targeted Drug Delivery
Li, Y., Zhu, X., Liang, H., Orvig, C., & Chen, Z. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200505085756 · Cited by 34
miR-199a-5p is involved in doxorubicin resistance of non-small cell lung cancer (NSCLC) cells
Jin, Y., Wang, H., Zhu, Y., Feng, H., Wang, G., & Wang, S. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173105 · Cited by 32
ICG/5-Fu coencapsulated temperature stimulus response nanogel drug delivery platform for chemo-photothermal/photodynamic synergetic therapy
Yao, S., Jin, X., Wang, C., Cao, A., Hu, J., Chen, B., & Wang, B. (2021) · Journal of Biomaterials Applications · doi:10.1177/0885328220988419 · Cited by 32
Tumor microenvironment dual-responsive core–shell nanoparticles with hyaluronic acid-shield for efficient co-delivery of doxorubicin and plasmid DNA
Wang, T., Yu, X., Han, L., Liu, T., Liu, Y., & Zhang, N. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s134378 · Cited by 31
Combining TRAIL and liquiritin exerts synergistic effects against human gastric cancer cells and xenograft in nude mice through potentiating apoptosis and ROS generation
Xie, R., Gao, C., Yang, X., Wu, S., Wang, H., Zhang, J., Yan, W., & Ma, T. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.06.095 · Cited by 32
A NIR-triggered multifunctional nanoplatform mediated by Hsp70 siRNA for chemo-hypothermal photothermal synergistic therapy
Zhang, B., Shao, C., Zhou, K.-M., Li, Q., Duan, Y., Yang, Y., & Zhu, H. (2021) · Biomaterials Science · doi:10.1039/d1bm01006a · Cited by 31
Nanomedicine-mediated drug targeting of cancer stem cells
Singh, D., Minz, A. P., & Sahoo, S. K. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.04.005 · Cited by 31
Rational Design of Multifunctional Polymeric Nanoparticles Based on Poly( l -histidine) and d-α-Vitamin E Succinate for Reversing Tumor Multidrug Resistance
Li, Z., Chen, Q., Qi, Y., Liu, Z., Hao, T., Sun, X., Qiao, M., Ma, X., Xu, T., Zhao, X., et al. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b00213 · Cited by 30
TIMP-2 regulates 5-Fu resistance via the ERK/MAPK signaling pathway in colorectal cancer
Zhang, G., Luo, X., Wang, Z., Xu, J., Zhang, W., Chen, E., Meng, Q., Wang, D., Huang, X., Zhou, W., et al. (2022) · Aging · doi:10.18632/aging.203793 · Cited by 30
Implications of nanotherapeutic advancements to leverage multi-drug resistant breast cancer: The state-of-the-art review
Aravindan, A., Gupta, A., Moorkoth, S., & Dhas, N. L. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106007 · Cited by 35
A Multi‐Mitochondrial Anticancer Agent that Selectively Kills Cancer Cells and Overcomes Drug Resistance
Peng, Y. B., Zhao, Z. L., Liu, T., Xie, G. J., Jin, C. Y., Deng, T., Sun, Y., Xiong, L., Hu, X. X., Zhang, X. B., et al. (2017) · ChemMedChem · doi:10.1002/cmdc.201600538 · Cited by 29
A tumor multicomponent targeting chemoimmune drug delivery system for reprograming the tumor microenvironment and personalized cancer therapy
Sau, S., Tatiparti, K., Alsaab, H. O., Kashaw, S. K., & Iyer, A. K. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.03.003 · Cited by 29
Self-citation
Leptin contributes to the taxol chemoresistance in epithelial ovarian cancer
Gu, F., Zhang, H., Yao, L., Jiang, S., Lu, H., Xing, X., Zhang, C., Jiang, P., & Zhang, R. (2019) · Oncology Letters · doi:10.3892/ol.2019.10381 · Cited by 28
Ratiometric drug delivery using non-liposomal nanocarriers as an approach to increase efficacy and safety of combination chemotherapy
Franco, M. S., & Oliveira, M. C. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.009 · Cited by 28
A new drug carrier with oxygen generation function for modulating tumor hypoxia microenvironment in cancer chemotherapy
Zhang, Z., Niu, N., Gao, X., Han, F., Chen, Z., Li, S., & Li, J. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.10.008 · Cited by 28
A Comprehensive Review on Current Treatments and Challenges Involved in the Treatment of Ovarian Cancer
Saman, S., Srivastava, N., Yasir, M., & Chauhan, I. (2023) · Current Cancer Drug Targets · doi:10.2174/1568009623666230811093139 · Cited by 27
A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery
Zhang, Q., Zhao, H., Li, D., Liu, L., & Du, S. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.10.018 · Cited by 27
Paclitaxel anticancer activity is enhanced by the MEK 1/2 inhibitor PD98059 in vitro and by PD98059-loaded nanoparticles in BRAFV600E melanoma-bearing mice
Mekkawy, A. I., Naguib, Y. W., Alhaj-Suliman, S. O., Wafa, E. I., Ebeid, K., Acri, T. M., & Salem, A. K. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120876 · Cited by 27
Nanomedicine to Overcome Cancer Multidrug Resistance
Yang, X., Cheng, Y. A., Luo, N., & Gong, C. (2014) · Current Drug Metabolism · doi:10.2174/1389200215666140926154443 · Cited by 27
The Application of Nanotechnology to Drug Delivery in Medicine
McDonald, T. O., Siccardi, M., Moss, D. M., Liptrott, N. J., Giardiello, M., Rannard, S. P., & Owen, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-444-62747-6.00007-5 · Cited by 26
Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach
Malhi, S. S., & Gu, X. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.998648 · Cited by 26
Nanoparticulate RNA delivery systems in cancer
Sharma, A., Jha, N. K., Dahiya, K., Singh, V. K., Chaurasiya, K., Jha, A. N., Jha, S. K., Mishra, P. C., Dholpuria, S., Astya, R., et al. (2020) · Cancer Reports · doi:10.1002/cnr2.1271 · Cited by 26
Cancer stem cells and nanomedicine: new opportunities to combat multidrug resistance?
Dalpiaz, A., Paganetto, G., Botti, G., & Pavan, B. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.07.023 · Cited by 28
New insight into the mechanisms of Ginkgo biloba leaves in the treatment of cancer
Yu, J., Wang, J., Yang, J., Ouyang, T., Gao, H., Kan, H., & Yang, Y. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155088 · Cited by 26
Multifunctional drug nanocarriers facilitate more specific entry of therapeutic payload into tumors and control multiple drug resistance in cancer
Mukherjee, B., Chakraborty, S., Mondal, L., Satapathy, B. S., Sengupta, S., Dutta, L., Choudhury, A., & Mandal, D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-42863-7.00007-4 · Cited by 26
Characterization, in vitro evaluation and comparative study on the cellular internalization of mesoporous silica nanoparticle-supported lipid bilayers
Yang, S., Song, S., Han, K., Wu, X., Chen, L., Hu, Y., Wang, J., & Liu, B. (2019) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2019.04.043 · Cited by 27
Solid lipid nanoparticles carrying lipophilic derivatives of doxorubicin: preparation, characterization, andin vitrocytotoxicity studies
Peira, E., Chirio, D., Battaglia, L., Barge, A., Chegaev, K. Y., Gigliotti, C. L., Ferrara, B., Dianzani, C., & Gallarate, M. (2016) · Journal of Microencapsulation · doi:10.1080/02652048.2016.1202342 · Cited by 25
Natural Melanin-Based Nanoparticles With Combined Chemo/Photothermal/Photodynamic Effect Induce Immunogenic Cell Death (ICD) on Tumor
Liu, D., Huang, H., Zhao, B., & Guo, W. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.635858 · Cited by 26
Nanoscale iron carboxylate metal organic frameworks as drug carriers for magnetically aided intracellular delivery
Sethi, K., Sharma, S., & Roy, I. (2016) · RSC Advances · doi:10.1039/c6ra18480d · Cited by 25
Functionalized Carbon Nanostructures Versus Drug Resistance: Promising Scenarios in Cancer Treatment
Curcio, M., Farfalla, A., Saletta, F., Valli, E., Pantuso, E., Nicoletta, F. P., Iemma, F., Vittorio, O., & Cirillo, G. (2020) · Molecules · doi:10.3390/molecules25092102 · Cited by 24
MicroRNA-1246 by Targeting AXIN2 and GSK-3β Overcomes Drug Resistance and Induces Apoptosis in Chemo-resistant Leukemia Cells
Xie, B., Li, L., Zhang, Z., Жао, Л., Cheng, J., Zhou, C., Cheng, J. J., Yan, J. Y., Chen, J., Yi, J., et al. (2021) · Journal of Cancer · doi:10.7150/jca.58522 · Cited by 24
Biocompatible Nanoparticles Based on Amphiphilic Random Polypeptides and Glycopolymers as Drug Delivery Systems
Zashikhina, N., Levit, M. L., Добродумов, А. В., Gladnev, S. V., Lavrentieva, A. V., Tennikova, T. B., & Korzhikova‐Vlakh, E. (2022) · Polymers · doi:10.3390/polym14091677 · Cited by 24
Effect of Cellular and Microenvironmental Multidrug Resistance on Tumor-Targeted Drug Delivery in Triple-Negative Breast cancer
Tezcan, O., Elshafei, A. S., Benderski, K., Rama, E., Wagner, M., Moeckel, D., Pola, R., Pechar, M., Etrych, T., von Stillfried, S. F., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.056 · Cited by 24
Nanoparticles combined with growth factors: recent progress and applications
Chu, C., Deng, J., Liu, L., Cao, Y., Wei, X., Li, J., & Man, Y. (2016) · RSC Advances · doi:10.1039/c6ra13636b · Cited by 24
Paclitaxel-loaded hollow-poly(4-vinylpyridine) nanoparticles enhance drug chemotherapeutic efficacy in lung and breast cancer cell lines
Contreras‐Cáceres, R., Leiva, M. C., Ortíz, R., Díaz, A., Perazzoli, G., Casado-Rodríguez, M. A., Melguizo, C., Baeyens, J. M., López‐Romero, J. M., & Prados, J. C. (2017) · Nano Research · doi:10.1007/s12274-016-1340-2 · Cited by 24
A Sequentially Responsive Nanosystem Breaches Cascaded Bio-barriers and Suppresses P-Glycoprotein Function for Reversing Cancer Drug Resistance
Liu, J., Zhao, L., Shi, L., Yuan, Y., Fu, D., Ye, Z., Li, Q., Deng, Y., Liu, X., Lv, Q., et al. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c13852 · Cited by 25
Near-IR Triggered Photon Upconversion
Burbano, D. C. R., Naccache, R., & Capobianco, J. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-444-63481-8.00273-6 · Cited by 23
Supramolecular nanofibers increase the efficacy of 10-hydroxycamptothecin by enhancing nuclear accumulation and depleting cellular ATP
Guo, Q., Liu, Y., Wang, Z., Zhang, J., Mu, G., Wang, W., & Liu, J. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.12.052 · Cited by 23
Nanomicelles co-loading CXCR4 antagonist and doxorubicin combat the refractory acute myeloid leukemia
Zhang, M., Ge, Y., Xu, S., Fang, X., Meng, J., Yu, L., Wang, C., Liu, J., Wen, T., Yang, Y., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106503 · Cited by 23
Revisiting the role of nanoparticles as modulators of drug resistance and metabolism in cancer
Gupta, P., Jani, K., Yang, D., Sadoqi, M., Squillante, E., & Chen, Z. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2016.1145655 · Cited by 24
Surface Engineering of Escherichia coli–Derived OMVs as Promising Nano-Carriers to Target EGFR-Overexpressing Breast Cancer Cells
Sepahdar, Z., Miroliaei, M., Bouzari, S., Khalaj, V., & Salimi, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.719289 · Cited by 22
Mitochondrial Artificial K+ Channel Construction Using MPTPP@5F8 Nanoparticles for Overcoming Cancer Drug Resistance via Disrupting Cellular Ion Homeostasis
Ma, P., Luo, Z., Li, Z., Lin, Y., Li, Z., Wu, Z., Ren, C., & Wu, Y. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202302012 · Cited by 22
Nanocarrier-based drug delivery system with dual targeting and NIR/pH response for synergistic treatment of oral squamous cell carcinoma
Li, R., Wan, C., Li, Y., Jiao, X., Liu, T., Gu, Y., Gao, R., Liu, J., & Li, B. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.114179 · Cited by 23
Dual-sensitive dual-prodrug nanoparticles with light-controlled endo/lysosomal escape for synergistic photoactivated chemotherapy
Lu, H., He, S., Zhang, Q., Li, X., Xie, Z., Wang, Z., Qi, Y., & Huang, Y. (2021) · Biomaterials Science · doi:10.1039/d1bm01154e · Cited by 21
Advanced diagnostic and therapeutic strategies in nanotechnology for lung cancer
Duan, Y., Shen, C., Zhang, Y., & Luo, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1031000 · Cited by 23
Biomimetic Nanobomb for Synergistic Therapy with Inhibition of Cancer Stem Cells
Liu, S., Zhang, T., Li, S., Wu, Q., Wang, K., Xu, X., Lu, M., Shao, R., Zhao, W., & Liu, H. (2023) · Small · doi:10.1002/smll.202206503 · Cited by 21
A Y 1 receptor ligand synergized with a P-glycoprotein inhibitor improves the therapeutic efficacy of multidrug resistant breast cancer
Wang, Y., Jiang, Z., Yuan, B., Tian, Y., Xiang, L., Li, Y., Yang, Y., Li, J., & Wu, A. (2019) · Biomaterials Science · doi:10.1039/c9bm00337a · Cited by 21
Photo-induced specific intracellular release EGFR inhibitor from enzyme/ROS-dual sensitive nano-platforms for molecular targeted-photodynamic combinational therapy of non-small cell lung cancer
Zhang, M., Zhang, X., Cai, S., Mei, H., He, Y., Huang, D., Shi, W., Li, S., Cao, J., & He, B. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb01053g · Cited by 21
Gambogic acid exhibits promising anticancer activity by inhibiting the pentose phosphate pathway in lung cancer mouse model
Zhang, Q., Zhang, Y., Wang, C., Tang, H., Ma, A., Gao, P., Shi, Q., Wang, G., Shen, S., Wang, J., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155657 · Cited by 20
Nanoenzymes: A Radiant Hope for the Early Diagnosis and Effective Treatment of Breast and Ovarian Cancers
Shahid, S., Khan, A. A., Shahid, W., Rehan, M., Asif, R., Nisar, H., Kanwal, Q., & Choi, J. R. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s460712 · Cited by 20
NER-factor DDB2 regulates HIF1α and hypoxia-response genes in HNSCC
Bommi, P. V., Chand, V., Mukhopadhyay, N. K., Raychaudhuri, P., & Bagchi, S. (2019) · Oncogene · doi:10.1038/s41388-019-1105-y · Cited by 20
Nanotechnological approaches for counteracting multidrug resistance in cancer
Martinelli, C., & Biglietti, M. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2020.47 · Cited by 21

Authors: Iyer, A. K., Singh, A., Ganta, S., & Amiji, M. M.
Affiliations: Northeastern University (US)
Nemucore Medical Innovations (United States) (US)
Corresponding author: Amiji, Mansoor M.
ORCID: Iyer, Arun K.
Amiji, Mansoor M.
Venue: Advanced Drug Delivery Reviews
Publisher: Elsevier BV
Published: 2013-11
Volume: 65
Issue: 13-14
Pages: 1784-1802
ISSN: 0169-409X (ISSN-L)
DOI: 10.1016/j.addr.2013.07.012
OpenAlex: W2000798536
Cited by: 343
References: 242
Citations by year: 2026: 6 · 2025: 16 · 2024: 31 · 2023: 26 · 2022: 28 · 2021: 32 · 2020: 26 · 2019: 33 · 2018: 30 · 2017: 31 · 2016: 33 · 2015: 23 · 2014: 27 · 2013: 1
FWCI: 1.90
Type: journal article
Language: en
Update notices: erratum (2026-04-04)
erratum (2026-07-01)
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Advanced Drug Delivery Reviews (publishedVersion)
PubMed (publishedVersion)
Topics: Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
Keywords: cancer nanomedicine, multidrug resistance, drug resistance, multifunctional nanoparticles, targeted drug delivery, cancer stem cells, efflux pumps, stimuli-responsive nanoparticles, tumor hypoxia, aerobic glycolysis, tumor recurrence
MeSH terms: Animals, Antineoplastic Agents, Drug Carriers, Humans, Neoplasms, Drug Delivery Systems, Drug Resistance, Neoplasm, Nanomedicine, Nanoparticles, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Role of integrated cancer nanomedicine in overcoming drug resistance

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks